Trials / Completed
CompletedNCT01945970
Effect of Black Tea on Vascular Function
Randomized Double Blind Placebo Controlled Crossover Study to Assess the Effect of Black Tea on Flow-Mediated Dilation in Healthy, Non-tea Drinking Males
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Unilever R&D · Industry
- Sex
- Male
- Age
- 40 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation (FMD).
Detailed description
The current study tests a specific Black tea extract against a placebo in population that has previously show to be sensitive to the effect of black tea on Flow Mediated dilation. A tea extract that has previously been shown to improve FMD is included as the positive control.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Black tea extract | Black tea extract |
| OTHER | Positive control | Positive control |
| OTHER | Placebo | Placebo |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2013-11-01
- Completion
- 2013-12-01
- First posted
- 2013-09-19
- Last updated
- 2017-03-22
- Results posted
- 2017-02-17
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01945970. Inclusion in this directory is not an endorsement.